Author: AFP AFP

RNS Number : 5187G Aberdeen Asia Focus plc 06 November 2025 abrdn Holdings Limited announces the unaudited net asset values (NAVs) of the following investment companies as at close of business on 31 October 2025. Unless otherwise disclosed, the NAVs have been calculated in accordance with the r…Read More

Read More

Hengrui, one of China’s leading pharmaceutical companies, is preparing to bring its cancer therapies to international markets. At the ESMO congress in Berlin, Yuting (Shelley) Liu, Head of China Business Development and Strategy of Hengrui Pharma, shared insights into how the company is translating decades of Chinese market experience into a global oncology strategy.Read More

Read More